Neal Schilling

This inventor holds 6 USPTO granted patents and 1 published patent application, plus 1 CIPO patent and 1 EPO patent. Top assignees: Heat Biologics, Inc., Heat Biologies, Inc., Kopfkino IP, LLC. Active years: 2018-2024.

USPTO Granted Patents = 6 (Patent Applications = 1)

% Patents Active = 100.0

CIPO Patents = 1

EPO Patents = 1 (Patent Applications = 2)

Average Co-Inventor Count = 4.0

ph-index = 2

Forward Citations = 10(Granted Patents)

Company Filing History:

Years Active: 2018-2024

Loading Chart...

6 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12178847 - Compositions and methods for adjoining type I and type II extracellular domains as heterologous chimeric proteins (2024-12-31),

2. 11654180 - Compositions and methods for adjoining type I and type II extracellular domains as heterologous chimeric proteins (2023-05-23),

3. 10660936 - Compositions and methods for adjoining type I and type II extracellular domains as heterologous chimeric proteins (2020-05-26),

4. 10653748 - Compositions and methods for adjoining type I and type II extracellular domains as heterologous chimeric proteins (2020-05-19),

5. 10449233 - Compositions and methods for adjoining type I and type II extracellular domains as heterologous chimeric proteins (2019-10-22),

6. 10086042 - Compositions and methods for adjoining type I and type II extracellular domains as heterologous chimeric proteins (2018-10-02),

Title: The Innovative Contributions of Neal Schilling

Introduction

Neal Schilling is a prominent inventor based in Durham, NC (US), known for his significant contributions to the field of biotechnology. With a total of six patents to his name, Schilling has focused on developing innovative solutions that address critical health challenges, particularly in the realm of immunotherapy.

Latest Patents

One of Schilling's latest patents is titled "Compositions and methods for adjoining type I and type II extracellular domains as heterologous chimeric proteins." This invention relates to compositions and methods, including chimeric proteins that are useful in the treatment of diseases such as cancer and autoimmunity. The invention provides various embodiments of fusions of extracellular domains of transmembrane proteins that can have either stimulatory or inhibitory effects. This work exemplifies Schilling's commitment to advancing medical science through innovative protein engineering.

Career Highlights

Throughout his career, Neal Schilling has worked with notable companies, including Heat Biologics, Inc. and Heat Biologies, Inc. His experience in these organizations has allowed him to apply his expertise in biotechnology and contribute to groundbreaking research and development efforts.

Collaborations

Schilling has collaborated with esteemed colleagues such as George Fromm and Suresh De Silva. These partnerships have further enriched his work and expanded the impact of his inventions in the scientific community.

Conclusion

Neal Schilling's innovative work in biotechnology, particularly in the development of chimeric proteins for immunotherapy, showcases his dedication to improving health outcomes. His contributions continue to influence the field and inspire future advancements in medical science.